FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial
NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III clinical trial in patients with Non-Small Cell Lung Cancer (NSCLC). The amendment will expand patient eligibility and [...]
For critically ill patients in intensive care units, use of a sponge containing the antimicrobial agent chlorhexidine gluconate as part of the dressing for catheters reduced the risk of major catheter-related infections, according to a study in the March 25 issue of JAMA. The researchers also found that reducing the frequency of changing unsoiled dressings [...]
MIT graduate student and synthetic biologist Timothy Lu is passionate about tackling problems that pose threats to human health. His current mission: to destroy antibiotic-resistant bacteria.
The 27-year-old M.D. candidate and Ph.D. in the Harvard-MIT Division of Health Sciences and Technology received the prestigious $30,000 Lemelson-MIT Student Prize for inventing processes that promise to combat bacterial [...]
It is possible that hospital types of antibiotic resistant Escherichia coli (E. coli) bacteria may soon infect patients in community settings. This would be a situation similar to that of community-acquired meticillin-resistant Staphylococcus aureus (MRSA), according to a Review published in March in The Lancet Infectious Diseases.
Often, these E. coli infections manifest themselves as urinary [...]
Although hospital superbugs like MRSA – methicillin resistant Staphylococcus aureus – are now a widespread and recognised problem, new MRSA strains that have emerged and are spreading amongst the wider public in the USA may pose a bigger threat, according to Exeter researchers speaking today (Wednesday 28 November 2007) at the Federation of Infection Societies [...]
A new study published in Veterinary Microbiology found methicillin-resistant Staphylococcus aureus (MRSA) prevalent in Canadian pig farms and pig farmers, pointing to animal agriculture as a source of the deadly bacteria.
The Veterinary Microbiology study (Khanna et al. 2007) is the first to show that North American pig farms and farmers commonly carry MRSA. The study [...]
A new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that America’s pharmaceutical research companies are now testing 338 new medicines to help treat infectious diseases, including 11 medicines and four vaccines to treat staphococcal infections. This is particularly important in light of increased public concern about the spread of methicillin-resistant [...]
Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, announced a new service to help hospitals combat methicillin-resistant staphylococcus aureus (MRSA) infections that are responsible for an estimated 94,000 life-threatening conditions and 18,650 deaths annually in the U.S.(1)
Cardinal Health is deploying a new MRSA Scorecard to [...]
Researchers in Bradford are investigating the effects of humidity on hospital ’super bugs’ using one of the largest known biological test chambers in the world.
The Bradford Infection Group (BIG), based within the University of Bradford’s Schools of Engineering, Design & Technology and Life Sciences, was recently awarded funding worth over £175,000 to investigate an alternative [...]
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
| By N2H | |||||||||||||